Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
AZN
Financials
Revenue by region
AZN
AstraZeneca PLC
Backtest
AZN
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Shares and dividends
Costs
Revenue by region
Revenue by region
2025, ended Dec 31, 2025
United States
$24.0B
41%
China
$6.6B
11%
United Kingdom
$4.4B
7%
Others, Europe
$4.3B
7%
Japan
$3.6B
6%
Germany
$2.9B
5%
Sweden
$2.6B
4%
All other
$10.4B
18%
Earlier:
UK
to 2021
Regions by fiscal year
CSV
Regions by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Outside the UK
54.4B
—
42.4B
41.2B
—
24.9B
—
—
—
—
—
The Americas
27.6B
25.0B
20.8B
19.6B
14.0B
10.3B
9.3B
8.5B
—
9.2B
—
Rest of Europe
13.5B
—
—
8.9B
—
—
—
—
—
—
—
Asia, Africa And Australasia
13.4B
—
11.9B
12.7B
12.3B
9.7B
9.1B
7.4B
—
6.4B
—
United Kingdom
4.36B
4.74B
3.37B
3.12B
—
—
—
—
—
—
—
Earlier (4)
—
—
—
—
3.25B
1.74B
1.82B
2.39B
3.24B
1.85B
6.88B
UK
—
—
—
—
3.25B
1.74B
1.82B
2.39B
3.24B
1.85B
—
External
—
—
—
—
—
—
22.6B
19.7B
—
—
—
Europe
—
—
—
—
—
—
4.16B
3.82B
—
—
—
Intra-Group
—
—
—
—
—
—
—
—
—
—
6.88B
Total
58.7B
54.1B
45.8B
44.4B
37.4B
26.6B
24.4B
22.1B
22.5B
23.0B
24.7B
More AstraZeneca financials
Revenue
Gross profit
Operating income
Net income
EPS
EBITDA
Revenue at other companies
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
HUM
Humana Inc.
HCA
HCA Healthcare, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
Tools
Return calculator